0001367644-22-000077.txt : 20220525
0001367644-22-000077.hdr.sgml : 20220525
20220525161235
ACCESSION NUMBER: 0001367644-22-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220524
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zoon Kathryn C
CENTRAL INDEX KEY: 0001685720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 22963035
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_165350953758392.xml
FORM 4
X0306
4
2022-05-24
0
0001367644
Emergent BioSolutions Inc.
EBS
0001685720
Zoon Kathryn C
400 PROFESSIONAL DRIVE
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2022-05-24
4
S
0
1996
35.53
D
12381
D
Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
/s/ S. Scott Lieberman, Attorney-in-fact
2022-05-25